YES, Medicare does now provide general coverage for amyloid PET scans for Alzheimer’s diagnosis, following an October 2023 policy change.

Being Patient Alexandra Marvar As of a landmark policy change in October 2023, Medicare now covers PET scans to look for Alzheimer’s biomarker beta-amyloid in the brain for the general public. Up to this point, the Centers for Medicare & Medicaid Services (CMS) had refused to provide general Medicare coverage for Beta Amyloid Positron Emission Tomography scans (PET scans […]

Nobel Prize Winners: Illuminating Excellence in Science

In the illustrious history of the Lindalh Lectures at the Napa Pain Conference, we have been privileged to host some of the most brilliant minds in the scientific community. Among them, several luminaries have gone on to receive the highest honor in their respective fields – the Nobel Prize. Let’s celebrate their remarkable contributions: 1.             Dr. […]

, , ,

30 Years of Groundbreaking Medical Education Features Award-Winning Speakers

CEO and Founder of Neurovations Dr. Eric Grigsby Celebrates Three Decades of Innovation in Chronic Pain Management at 30th Napa Pain Conference NAPA, Calif., September 12, 2023 ( – The 30th Napa Pain Conference concluded on Aug. 20, 2023, celebrating three decades of unwavering commitment to advancing treatments and research for pain and neurological disease. The […]

, , ,

Sonoma and Napa County researchers participate in drug trials aimed at preventing Alzheimer’s disease

MARTIN ESPINOZA THE PRESS DEMOCRAT Sonoma County neurologist Dr. Allan Bernstein envisions a day when Alzheimer’s disease can be treated as successfully as heart disease or even cancer. That day is far off, he said, but we’re getting closer. Bernstein, who has been involved in Alzheimer’s research for nearly 25 years, said part of the […]


Dr. Eric Grigsby Collaborates on Groundbreaking Study of Donanemab’s Impact on Alzheimer’s Disease

Neurovations Research proud to be a part of study that  released first positive results to slow Alzheimer’s Disease Napa, Calif., July 17, 2023 – Neurovations, a leading medical research and innovation company, is proud to have collaborated on a groundbreaking study investigating the effects of the monoclonal antibody, donanemab, on patients with the early stages […]

, ,

Dr. Melanie Johansson Joins the Napa Pain Institute

The Pain Institute welcomes newestpain intervention physician to the Napa Community June 1, 2023, Napa, Ca – Dr. Melanie Johansson joins the Napa Pain Institute as a fellowship-trained and board-certified pain management specialist with well over a decade of medical experience. Dr. Johansson treats patients for chronic back pain, headache and neuropathic pain, osteoporosis, chronic […]


Neurovations Receives 2022 Best of Napa Award for Outstanding COVID Testing Services

Local Healthcare Entrepreneur Eric Grigsby, MD, MBA, is recognized for his efforts to keep Napa Community safe NapaCovid has been selected for the 2022 Best of Napa Award in the Medical Clinic category. Dr. Eric Grigsby, founder and CEO of Neurovations and Napa-based N3 Laboratories, supplied infrastructure for testing sites including a website, online and […]


Spinal cord stimulation advances therapy for painful diabetic peripheral neuropathy

By Dr. Eric Grigsby Dr. Eric Grigsby, CEO and Found of Neurovations Diabetic peripheral neuropathy is a debilitating, progressive neurologic disorder that affects about 30% of adults with diabetes. Spinal cord stimulation is a newer option for addressing moderate to severe pain related to the condition. Red the Story on Endorcrinetoday The post Spinal cord […]

, ,